AstraZeneca, GSK, Teva All On FTC’s Notice Due To “Improperly Listed” Patents
The U.S. Federal Trade Commission (FTC) issued letters to various medical device companies and drugmakers, including AbbVie, AstraZeneca, and subsidiaries
Read more
Orange Book